ArticleBrain & spine2025
Recurrence prediction in chronic subdural hematomas: a risk stratification score based on 118 consecutive patients.
Article in Brain & spine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Postoperative Density of Residual Hematoma Is a Predictor of Chronic Subdural Hematoma Recurrence-A Single-Center Retrospective Study.Neurology international · 2026Article
- Chronic Subdural Hematoma Is Not Subdural: Anatomical, Biological, and Therapeutic Implications of a Misleading Definition.Brain sciences · 2026Article
- Classification of recurrence status after surgical treatment of chronic subdural hemorrhage - A machine learning approach.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic subdural hematoma (CSDH) is a frequent neurosurgical condition with a significant recurrence rate. Identifying patients at risk of recurrence is a topic of great interest to intercept this population in which to implement further therapeutic strategies. Objective: To develop and internally validate a risk-stratification score using preoperative radiological parameters to predict risk of CSDH recurrency. To establish a stratification approach based on easily available clinical and radiological variables. Methods: A retrospective analysis of 118 consecutive patients surgically treated for CSDH was conducted. Binary logistic regression was used to identify radiological preoperative predictors of recurrence, including Nakaguchi classification, cortical atrophy, and hematoma density. Results: A weighted scoring system has been developed and patients were stratified into three risk categories: low (0-2 points), moderate (3-5 points), and high (6-8 points). This grading system demonstrated a significant correlation with recurrence rates: 0 % in the low-risk group, 11.76 % in the moderate-risk group, and 25.71 % in the high-risk group. The model exhibited good discriminative ability in predicting the risk of CSDH recurrence. Conclusion: Hyperdense appearance, homogeneous or separated Nakaguchi-configuration and presence of cortical atrophy are predictive features of CSDH recurrence and can be incorporated into a score. The proposed grading system provides an effective preoperative tool for assessing CSDH recurrence risk, with a progressive increase in the recurrency rate between the three groups. This model enables personalized postoperative management, facilitating early identification of high-risk patients who may benefit from adjunctive treatments to reduce recurrence.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.